Bibliography
- SELA M, HURWITZ E: Conjugates of antibodies with cytotoxic drugs. In: Immunoconjugates. Vogel CW (Ed.), Oxford University Press, New York (1987):189–216.
- RODWELL JD: Antibody-Mediated Delivery Systems. Mar-cel Dekker, New York (1988).
- PIETERSZ GA: The linkage of cytotoxic drugs to mono-clonal antibodies for the treatment of cancer. BioCon-jugate Chem. (1990) 1:89–95.
- STARLING JJ, MACIAK RS, LAW KL et al.: In vivo antitu-mour activity of a monoclonal antibody- Vinca alkaloid immunoconjugate directed against a solid tumour membrane antigen characterized by heterogeneous ex-pression and noninternalization of antibody-antigen complexes. Cancer Res. (1991) 51:2965–2972.
- TRAIL PA, WILLNER D, LASCH SJ et al: Cure of xenografted human carcinoma by BR96-doxorubicin immunocon-jugates. Science (1993) 261:121–215.
- ELIAS DJ, HIRSHOWITZ L, KLINE LE etal.: Phase I clinical comparative study of monoclonal antibody KS1/4 and KS1/4-methotrexate immunoconjugate in patients with non-small cell lung cancer. Cancer Res. (1990) 50:4154–4159.
- ELIAS DJ, KLINE LE, ROBBINS BA et al.: Monoclonalantibody KS1/4-methotrexate immunoconjugate in non-small cell lung carcinoma. Am. J. Respir. Grit Care Med. (1994) 150:1114–1122.
- SCHNECK D, BUTLER F, DUGAN W et al.: Disposition of a murine monoclonal antibody Vinca conjugate (K5I/4-DAVLB) inpatients with adenocarcinoma. Clin. Pharma-col. Ther. (1990) 47:36–41.
- CHARI RVJ, MARTELL BA, GROSS JL et al: Immunoconju-gates containing novel maytansinoids: promising anti-cancer drugs. Cancer Res. (1992) 52:127–131.
- LIU C, TADAYONI BM, BOURRET LA et al: Eradication of large colon tumour xenografts by targeted delivery of maytansinoids. Proc. Natl. Acad. Sci. USA (1996) 93:8618–8623.
- REMILLARD S, REBHUN LI, HOWIE GA, KUPCHAN SM: Antimitotic activity of the potent tumour inhibitor maytansine. Science (1977) 189:1002–1005.
- LAMBERT JM, BLATTLER WA, MCLNTYRE GD et al.: Immu-notoxins containing single chain ribosome-inactivat-ing proteins. In: Immunotoxins. Frankel AE (Ed.), Kluwer Academic Publishers, Norwell, MA (1988):175–209.
- SHEN WC, RYSER HP, LAMANNA L: Disulphide spacer between methotrexate and poly(D-lysine) . J. Biol. Chem. (1985) 260:10905–10908.
- GOLDMACHER VS, TINNEL NL, NELSON BC: Evidence that pinocytosis in lymphoid cells has a low capacity. J. Cell. Biol. (1986) 102:1312–1319.
- BAECKSTROM D, HANSSON GC, NILSSON 0 et al: Purifi-cation and characterization of a membrane-bound and secreted mucin-type glycoprotein carrying the carci-noma-associated sialyl-Lea epitope on distinct core pro-teins. J. Biol. Chem. (1991) 266:21537–21547.
- MCKENZIE SJ, MARKS PJ, LAM T et al.: Generation and characterization of monoclonal antibodies specific for the human neu oncogene product p185. Oncogene (1989) 4:543–548.
- BLATTLER WA, CHARI RVJ, LAMBERT JM: Immunoconju-gates. In: The Cancer Therapeutics Handbook. Telcher B (Ed.), Humana Press, Inc., Totowa, NJ (1996):369–392.
- ROGUSKA MA, PEDERSON JT, KEDDY CA et al: Humani-zation of murine monoclonal antibodies through vari-able domain resurfacing. Proc. Natl. Acad. Sci. USA (1994) 91:969–973.